Type 1 plasminogen activator inhibitor (PAI-1) in Clear cell renal cell carcinoma (CCRCC) and its impact on angiogenesis, progression and patient survival after radical nephrectomy

Zubac, D. P., Wentzel-Larsen, T., Seidal, T., & Bostad, L. (2010). Type 1 plasminogen activator inhibitor (PAI-1) in Clear cell renal cell carcinoma (CCRCC) and its impact on angiogenesis, progression and patient survival after radical nephrectomy. BMC Urology. doi:10.1186/1471-2490-10-20